NCT07204340
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07204340
Title TLN-372 in Advanced KRAS Mutant Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Treeline Biosciences, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | CAN | AUS

Facility Status City State Zip Country Details
University of Alabama at Birmingham RECRUITING Birmingham Alabama 35294 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215-5450 United States Details
START Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
Washington University Medical Campus RECRUITING St Louis Missouri 63108 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10021-3402 United States Details
Sarah Cannon Research Institute RECRUITING Nashville Tennessee 37203 United States Details
Peter MacCallum Cancer Centre RECRUITING Melbourne Victoria Australia Details
Linear Clinical Research RECRUITING Perth Western Australia 6009 Australia Details
Princess Margaret Cancer Centre RECRUITING Toronto Ontario M5G 1X6 Canada Details
START Madrid_Hospital Universitario HM Sanchinarro_CIOCC RECRUITING Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field